A Feasibility Study of the Therapeutic Response and Durability of Short-term Androgen-targeted Therapy in Early Prostate Cancer Managed with Surveillance: The Therapeutics in Activ...

by Tristan Barrett, Simon Pacey, Kelly Leonard, Jerome Wulff, Ionut-Gabriel Funingana, Vincent Gnanapragasam
Published 2022-04-01

Radiomic and Volumetric Measurements as Clinical Trial Endpoints—A Comprehensive Review

by Ionut-Gabriel Funingana, Pubudu Piyatissa, Marika Reinius, Cathal McCague, Bristi Basu, Evis Sala
Published 2022-10-01

Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

by Leonardo Rundo, Leonardo Rundo, Lucian Beer, Lucian Beer, Lucian Beer, Lorena Escudero Sanchez, Lorena Escudero Sanchez, Mireia Crispin-Ortuzar, Mireia Crispin-Ortuzar, Mireia Crispin-Ortuzar, Marika Reinius, Marika Reinius, Marika Reinius, Cathal McCague, Cathal McCague, Hilal Sahin, Hilal Sahin, Hilal Sahin, Vlad Bura, Vlad Bura, Vlad Bura, Roxana Pintican, Roxana Pintican, Marta Zerunian, Stephan Ursprung, Iris Allajbeu, Iris Allajbeu, Helen Addley, Paula Martin-Gonzalez, Paula Martin-Gonzalez, Thomas Buddenkotte, Naveena Singh, Anju Sahdev, Ionut-Gabriel Funingana, Ionut-Gabriel Funingana, Ionut-Gabriel Funingana, Mercedes Jimenez-Linan, Mercedes Jimenez-Linan, Florian Markowetz, Florian Markowetz, James D. Brenton, James D. Brenton, James D. Brenton, Evis Sala, Evis Sala, Evis Sala, Ramona Woitek, Ramona Woitek, Ramona Woitek
Published 2022-06-01

Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma

by Philip Smith, Thomas Bradley, Lena Morrill Gavarró, Teodora Goranova, Darren P. Ennis, Hasan B. Mirza, Dilrini De Silva, Anna M. Piskorz, Carolin M. Sauer, Sarwah Al-Khalidi, Ionut-Gabriel Funingana, Marika A. V. Reinius, Gaia Giannone, Liz-Anne Lewsley, Jamie Stobo, John McQueen, Gareth Bryson, Matthew Eldridge, The BriTROC Investigators, Geoff Macintyre, Florian Markowetz, James D. Brenton, Iain A. McNeish
Published 2023-09-01

The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma

by Philip Smith, Thomas Bradley, Lena Morrill Gavarró, Teodora Goranova, Darren P. Ennis, Hasan B. Mirza, Dilrini De Silva, Anna M. Piskorz, Carolin M. Sauer, Sarwah Al-Khalidi, Ionut-Gabriel Funingana, Marika A. V. Reinius, Gaia Giannone, Liz-Anne Lewsley, Jamie Stobo, John McQueen, Gareth Bryson, Matthew Eldridge, The BriTROC Investigators, Geoff Macintyre, Florian Markowetz, James D. Brenton, Iain A. McNeish
Published 2023-07-01

Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial

by James Spicer, Bristi Basu, Ana Montes, Udai Banerji, Rebecca Kristeleit, Rowan Miller, Gareth J. Veal, Christopher J. Corrigan, Stephen J. Till, Mariangela Figini, Silvana Canevari, Claire Barton, Paul Jones, Sarah Mellor, Simon Carroll, Chris Selkirk, George Nintos, Vineet Kwatra, Ionut-Gabriel Funingana, Gary Doherty, Hannah J. Gould, Giulia Pellizzari, Mano Nakamura, Kristina M. Ilieva, Atousa Khiabany, Chara Stavraka, Jitesh Chauhan, Cheryl Gillett, Sarah Pinder, Heather J. Bax, Debra H. Josephs, Sophia N. Karagiannis
Published 2023-07-01